Loading...
*  Whole Blood Platelet Aggregation in Chronic Kidney Disease on Aspirin and Clopidogrel Study
... Study ID. STU 082012-089 ... Participants with also be asked to not eat foods known to affect platelet function (coffee, chocolate, grapes, and alcohol) 48 ... known to affect platelet function will be assessed and patients on those will be asked to discontinue these. ... platelet factor 4, beta thromboglobulin and VWF antigen levels and activity). Participants will be administered aspirin 81 mg ...
http://www.utsouthwestern.edu/research/fact/detail.html?studyId=STU%20082012-089
*  Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study - Full Text View - ClinicalTrials.gov
Whole Blood Platelet Aggregation to 2 µg/mL collagen [ Time Frame: 2 weeks ]. Compare the inhibition of Whole Blood Platelet ... Poor inhibition of platelet aggregation by anti-platelet agents predicts future cardiovascular events. Clinical practice ... Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study (WiCKDonASA). The safety and scientific ... Whole Blood Platelet Aggregation to 20 µg/mL Adenosine Diphosphate [ Time Frame: 2 weeks ]. Compare the inhibition of Whole ...
https://clinicaltrials.gov/ct2/show/NCT01768637?recr=Open&cond=%22Platelet+Aggregation+Inhibitors%22&rank=19
*  Platelet Aggregation
Patient's whole blood platelet count must be ,112,500/cu mm (add-on complete blood count (CBC, CPT 85027) and clot retraction ... Platelet Aggregation. Platelet aggregation Core Lab, Coagulation. Battery Members. Agonists include ADP, Arachidonic Acid, ...
https://www.nationwidechildrens.org/specialties/laboratory-services/lab-test-directory/platelet-aggregation
*  platelet aggregation inhibitor (CHEBI:50427)
... platelet aggregation inhibitor (CHEBI:50427). δ-guaiene (CHEBI:63447) has role platelet aggregation inhibitor (CHEBI:50427). (E ... platelet aggregation inhibitor (CHEBI:50427). (S)-glaucine (CHEBI:5373) has role platelet aggregation inhibitor (CHEBI:50427). ... platelet aggregation inhibitor (CHEBI:50427). S-nitroso-L-cysteine (CHEBI:138935) has role platelet aggregation inhibitor ( ... platelet aggregation inhibitor (CHEBI:50427). benzo[d]isothiazol-3-one (CHEBI:167099) has role platelet aggregation inhibitor ( ...
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:50427
*  Platelet Aggregation Studies
... ,ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative ... Platelet Incubator TPSRI-16. 4. Platelet Incubator 3603. 5. Platelet Incubator 3606. 6. Platelet Incubator 3609. 7. i. Series ... Platelet Incubator 3612. 9. i. Series Floor Model Platelet Incubator PC4200i. 10. i. Series Floor Model Platelet Incubator ...
http://www.bio-medicine.org/medicine-products/Platelet-Aggregation-Studies-24170-1/
*  Spontaneous platelet aggregation reversed by flurbiprofen. | The BMJ
Spontaneous platelet aggregation reversed by flurbiprofen. Br Med J 1978; 1 :1323 ... Spontaneous platelet aggregation reversed by flurbiprofen.. Br Med J 1978; 1 doi: https://doi.org/10.1136/bmj.1.6123.1323-a ( ...
http://www.bmj.com/content/1/6123/1323.2
*  Platelet Aggregation Inhibitors - DrugBank
This project is supported by the Canadian Institutes of Health Research (award #111062), Alberta Innovates - Health Solutions, and by The Metabolomics Innovation Centre (TMIC), a nationally-funded research and core facility that supports a wide range of cutting-edge metabolomic studies. TMIC is funded by Genome Alberta, Genome British Columbia, and Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with funding from the federal government. Maintenance, support, and commercial licensing is provided by OMx Personal Health Analytics, Inc. Designed by Educe Design & Innovation Inc. ...
https://www.drugbank.ca/indications/DBCOND0034628
*  Platelet Aggregation: Reference Range, Interpretation, Collection and Panels
The reference range is a normal biphasic pattern of aggregation in response to specific platelet activators (see image below).{ ... Platelet Aggregation) and Platelet Aggregation What to Read Next on Medscape. Related Conditions and Diseases. * Platelet ... Platelet aggregation studies test the clumping response of platelets to various platelet activators (eg, ADP, collagen, ... Platelet secretion defects can provide greater diagnostic sensitivity than platelet aggregation testing alone. [1, 2, 3] ...
https://emedicine.medscape.com/article/2085904-overview
*  Aggredyne receives FDA clearance for ADP platelet aggregation testing cartridge
Platelet testing and research company Aggredyne, Inc. has received U.S. Food and Drug Administration (FDA) clearance for ... ... Aggredyne receives FDA clearance for ADP platelet aggregation testing cartridge. News provided by ... instrument and associated assays for testing platelet aggregation in the individual patients. The company's patented products ... The company is also developing additional assays to be used with its instrument(s) in the anti-platelet therapy field as well ...
https://www.prnewswire.com/news-releases/aggredyne-receives-fda-clearance-for-adp-platelet-aggregation-testing-cartridge-300825857.html
*  Inhibitory Effect of Propolis on Platelet Aggregation In Vitro
The Platelet Aggregation Tests. Human platelet suspensions were prepared as previously described [27]. In this study, human ... Each person had his/her own 0% PRP and 100% PPP aggregation calibration. Before aggregation was started, standard platelet ... The Inhibition Effect of Different Components on Platelet Aggregation Induced by Different Agonists. Results of the platelet ... and the most antiplatelet aggregation effect occurred in the collagen-included platelet aggregation test group with an ...
https://www.hindawi.com/journals/jhe/2017/3050895/
*  HIPAA - Heparin-Induced Platelet Aggregation Assay | AcronymFinder
HIPAA stands for Heparin-Induced Platelet Aggregation Assay. HIPAA is defined as Heparin-Induced Platelet Aggregation Assay ... How is Heparin-Induced Platelet Aggregation Assay abbreviated? ... Induced-Platelet-Aggregation-Assay-(HIPAA).html. *APA style: ... Induced-Platelet-Aggregation-Assay-(HIPAA).html',HIPAA,/a,. ... Induced-Platelet-Aggregation-Assay-(HIPAA).html. *Chicago style ... n.d.) Acronym Finder. (2019). Retrieved July 21 2019 from https://www.acronymfinder.com/Heparin_Induced-Platelet-Aggregation- ...
https://www.acronymfinder.com/Heparin_Induced-Platelet-Aggregation-Assay-
*  Platelet aggregation test | Health Encyclopedia | FloridaHealthFinder.gov
Platelet aggregation test. Definition. The platelet aggregation blood test checks how well platelets, a part of blood, clump ... Platelet aggregation - blood; platelet aggregation, hypercoagulable state - blood. In: Chernecky CC, Berger BJ, eds. Laboratory ... platelet count. It may also be ordered if a member of your family is known to have a bleeding disorder due to platelet ... When platelets clump together, the blood sample is clearer. A machine measures the changes in cloudiness and prints a record of ...
http://www.floridahealthfinder.gov/healthencyclopedia/Health%20Illustrated%20Encyclopedia/1/003669.aspx
*  Platelet Aggregation Devices by Product & Application - 2020 | MarketsandMarkets
Platelet Aggregation Devices Market Report Categories the Global Market by Application (Diagnostic, Research, Orthopedic, CVD, ... Figure 27 Platelet Aggregation Systems to Contribute the Maximum to the Platelet Aggregation Products Market Growth in the U.S ... Table 16 Global Platelet Aggregation Devices Market Size, By End User, 2013 2020 (USD Million). Table 17 Platelet Aggregation ... 4.2 Global Platelet Aggregation Devices Market, By Region (2015 2020) 4.3 Platelet Aggregation Devices Market, By Product (2015 ...
https://www.marketsandmarkets.com/Market-Reports/platelet-aggregation-device-market-208068983.html
*  Whole Blood Platelet Aggregation and Release Reaction Testing in Uremic Patients
We employed whole blood platelet aggregation analysis based on impedance as well as determination of ATP release from platelet ... Whole Blood Platelet Aggregation and Release Reaction Testing in Uremic Patients. Jay Zeck,1 Jason Schallheim,1 Susie Q. Lew,2 ... ATP release had a low response to arachidonic acid (0.37 ± 0.26 nmoles, reference range: 0.6-1.4 nmoles). Platelet aggregation ... Platelet function analysis utilizing platelet-rich plasma and optical density based aggregometry fails to identify patients at ...
https://www.hindawi.com/journals/bmri/2013/486290/abs/
*  POPULATION BALANCE ANALYSIS OF SHEAR-INDUCED PLATELET AGGREGATION
... one measure indirectly assesses the adhesiveness of platelets during aggregation. Kinetic data from shear-induced aggregation ... Moreover, aggregation in the shear field disappears at sufficiently low platelet concentrations (below about 60,000/mm('3) ... The work herein examines in vitro platelet aggregation in response to fluid shearing motion. Our specific aim is to ... of platelets in the shear field above a threshold shearing rate of about 2000 sec('-1) but diminishing platelet adhesiveness ...
https://scholarship.rice.edu/handle/1911/15803
*  Indications for platelet aggregation inhibitors after venous stents
Iliofemoral venous obstruction may arise from either primary compressive lesions or may be secondary to an episode of deep venous thrombosis. Regardless of aetiology, these lesions, either alone or in association with more distal reflux, may be responsible for lower extremity pain, swelling, and ulceration. Conventional surgical procedures for the treatment of iliofemoral venous obstruction have largely been supplanted by endovascular approaches relying on the deployment of venous stents. Large series have reported good technical and clinical results from venous stenting, particularly for primary lesions. However, early stent occlusions and late re-stenosis do occur. Although most of these appear related to technical factors, there is likely a role for pharmacological adjuncts in maintaining stent patency. The use of anticoagulants and antiplatelet agents is largely based on the underlying pathophysiology and extrapolation from arterial interventions, which likely are significantly different ...
https://insights.ovid.com/phle/201328011/00010435-201328011-00018
*  Novel platelet aggregation inhibitor for the treatment and prophylaxis of cardiovascular diseases
... 04.04.2006 ... in human platelets, more specifically of MRP4.. Further Information: PDF PVA Mecklenburg-Vorpommern AG. Phone: +49 (0)381/49 74 ...
http://www.innovations-report.com/html/reports/technology-offerings/report-98850.html
*  Pilot Study on Shear-induced Platelet Aggregation in Acute Coronary Syndromes
... clinicaltrials.gov The purpose of this study is to determine whether shear-induced platelet aggregation is able to discriminate ... Platelet aggregation and leucocyte activation seem to be involved in the pathogenesis. The aim of our study is to compare SIPA ... More From BioPortfolio on "Pilot Study on Shear-induced Platelet Aggregation in Acute Coronary Syndromes". *Related Companies* ... The purpose of this study is to determine whether shear-induced platelet aggregation is able to discriminate first acute ...
https://www.bioportfolio.com/resources/trial/109010/Pilot-Study-on-Shear-induced-Platelet-Aggregation-in-Acute-Coronary-Syndromes.html
*  Platelet aggregation inhibitor | definition of Platelet aggregation inhibitor by Medical dictionary
What is Platelet aggregation inhibitor? Meaning of Platelet aggregation inhibitor medical term. What does Platelet aggregation ... Looking for online definition of Platelet aggregation inhibitor in the Medical Dictionary? Platelet aggregation inhibitor ... redirected from Platelet aggregation inhibitor) Antiplatelet drug. Drug that inhibits platelets from aggregating to form a plug ... Platelet aggregation inhibitor , definition of Platelet aggregation inhibitor by Medical dictionary https://medical-dictionary. ...
https://medical-dictionary.thefreedictionary.com/Platelet+aggregation+inhibitor
*  Global Platelet Aggregation System Sales Market Report 2017 : ReportsnReports
In this report, the global Platelet Aggregation System market is... ... Check for Discount on Global Platelet Aggregation System Sales Market Report 2017 report by QYResearch Group. ... 2.2 Global Platelet Aggregation System (Volume and Value) by Type. 2.2.1 Global Platelet Aggregation System Sales and Market ... 2.3 Global Platelet Aggregation System (Volume and Value) by Region. 2.3.1 Global Platelet Aggregation System Sales and Market ...
https://www.reportsnreports.com/reports/1272674-global-platelet-aggregation-system-sales-market-report-2017.html
*  China Platelet Aggregation System Market Research Report 2018 : ReportsnReports
The global Platelet Aggregation System market is valued at XX... ... Check for Discount on China Platelet Aggregation System Market ... China Platelet Aggregation System Market Research Report 2018 Table of Contents. China Platelet Aggregation System Market ... 3.3 China Platelet Aggregation System Price (USD/Unit) by Regions (2012-2017). 4 China Platelet Aggregation System Sales and ... 4.4 China Platelet Aggregation System Sales Growth Rate (%) by Type (2012-2017). 5 China Platelet Aggregation System Sales by ...
http://www.reportsnreports.com/reports/1335530-china-platelet-aggregation-system-market-research-report-2018.html
*  Platelet Aggregation During the Shift From Clopidogrel to Ticagrelor - Full Text View - ClinicalTrials.gov
Platelet aggregation [ Time Frame: 2 hours ]. Platelet aggregation is measured by means of Multiple Electrode Aggregometry (MEA ... Platelet Aggregation During the Shift From Clopidogrel to Ticagrelor (SHIFT-OVER). The safety and scientific validity of this ... Platelet Aggregation During Pharmacological Shift From Clopidogrel to Ticagrelor in Patients With Acute Coronary Syndrome. ... Platelet Aggregation Inhibitors. Purinergic P2Y Receptor Antagonists. Purinergic P2 Receptor Antagonists. Purinergic ...
https://clinicaltrials.gov/show/NCT01795820
*  Platelet Aggregation Devices Market Is Expected To Generate Huge Profits by 2021
... technological improvement in platelet aggregometers, demand for platelet screening programs to identify diseases. ... The market growth of global platelet aggregation devices market has been accelerated by geriatric population across the globe, ... Platelet Aggregation Devices Market Is Expected to Generate Huge Profits by 2021. Platelet Aggregation Devices Market Forecast ... This report segments the global platelet aggregation devices market as follows:. Platelet Aggregation Devices Market: Product ...
http://www.sbwire.com/press-releases/platelet-aggregation-devices/release-769289.htm
*  The Effect of Short-Toothed and Dalmatian Sage Extracts on Platelet Aggregation
"The Effect of Short-Toothed and Dalmatian Sage Extracts on Platelet Aggregation." Food Technology and Biotechnology 56, br. 2 ( ... Cytotoxicity, anti-platelet aggregation assay and chemical components analysis of thirty-eight kinds of essential oils. Yao Wu ... "The Effect of Short-Toothed and Dalmatian Sage Extracts on Platelet Aggregation." Food Technology and Biotechnology, vol. 56, ... 2018). 'The Effect of Short-Toothed and Dalmatian Sage Extracts on Platelet Aggregation', Food Technology and Biotechnology, 56 ...
https://hrcak.srce.hr/index.php?show=clanak&id_clanak_jezik=299542
*  ATC - B01AC30 - Platelet aggregation inhibitors excluding heparin, combinations - Drugs-about.com
Platelet aggregation inhibitors excluding heparin, combinations. The Anatomical Therapeutic Chemical (ATC) classification ... B01AC30 - Platelet aggregation inhibitors excluding heparin, combinations *Platelet aggregation inhibitors excluding heparin, ...
https://drugs-about.com/atc/b01ac30.html